Whitepaper: Beta-glucans in purified water – do they really cause overestimation of endotoxin values?
Over the last century, the bacterial endotoxin test (BET) has evolved to keep pace with modern technology and lab expectations: from rabbit pyrogen testing to Limulus amebocyte lysate (LAL), to current developments with recombinant horseshoe crab coagulation factors.
The advancement of process and product testing methodology has been historically important as they benefit patient safety and can result in sustainable and non-inferior testing capacity. There are currently three commercially available recombinant Factor C (rFC) reagents and a fully recombinant LAL (rLAL) in development by Charles River. Global compendia’s current position is that recombinant LAL requires validation as an alternative method.
Related content from this organisation
- On-demand webinar: Celsis® for sterility – product spotlight
- Product hub: How can you ensure product quality if you are not in control of your manufacturing environment?
- On-demand webinar: Optimising MALDI-TOF for filamentous fungi ID
- Rapid microbiology testing market set to be worth over $6 billion in 2026
- Whitepaper: Beta-glucans in purified water – do they really cause overestimation of endotoxin values?